Continuing Education ...for the Pharmacist
Login Logout My CE Create Account Home

Enrollment  
Number:  
Password:  


|

 
 
 

Pharmacy Law Column

Risks associated with opioid drugs and the requirement of an opioid-wide REMS program
Matthew Seamon, PharmD, Esq. is a licensed pharmacist and attorney. Dr. Seamon is currently an Associate Professor in Pharmacy Practice at Nova Southeastern University College of Pharmacy where he teaches pharmacy law and serves Of Counsel to the law firm Fuerst Ittleman where he consults primarily on matters relating to biologic and drug regulation.
Opioids are extremely well-suited for REMS as the products are highly effective yet pose significant risk. Accordingly, the FDA has recently implemented the following REMS for opioids. Read More
Newly Released Lessons
Risks associated with opioid drugs and the requirement of an opioid REMS program (Knowledge-based activity)
Asthma: Considerations for pharmacy technicians (Knowledge-based activity)
Hepatitis C: New therapies and new horizons (Knowledge-based activity)
The homeopathic treatment of upper respiratory infections (Knowledge-based activity)
The safe harbor of pharmacy compounding; avoiding pharmaceutical manufacturing provisions (Knowledge-based activity)

Browse all lessons
Max-Wellness launches healthcare kiosks, revamps website offering
Study: Bausch + Lomb's Biotrue helps maintain tear film's natural antibacterial activity
Survey: Endocrinologists would prescribe Bydureon for 20% of patients
Teva launches generic schizophrenia, bipolar disorder drug
Performance booster supplement DMAA draws national media attention
American Diabetes Association appoints chief scientific and medical officer
Regulatory waiting period for Bristol's Inhibitex acquisition expires
FDA approves Merck diabetes drug
   
 

Login | Logout | My CE | Create Account | Home
Help | CE Lessons | Lesson Categories | Take Test | Search | About Us | FAQs

View our Privacy Statement

ACPEDrug Store News is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.